VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $661,114 | -18.0% | 24,568 | -8.3% | 0.04% | -12.2% |
| Q2 2023 | $806,324 | +67.9% | 26,779 | +80.4% | 0.05% | +58.1% |
| Q1 2023 | $480,336 | +16.5% | 14,848 | +3.2% | 0.03% | +6.9% |
| Q4 2022 | $412,182 | +111300.5% | 14,382 | -6.3% | 0.03% | 0.0% |
| Q3 2022 | $370 | -12.1% | 15,344 | -0.2% | 0.03% | -12.1% |
| Q2 2022 | $421 | -28.8% | 15,375 | -0.3% | 0.03% | -17.5% |
| Q1 2022 | $591 | +24.2% | 15,419 | +3.8% | 0.04% | +8.1% |
| Q4 2021 | $476 | +36.0% | 14,861 | +25.2% | 0.04% | +8.8% |
| Q3 2021 | $350 | +6.4% | 11,874 | +22.8% | 0.03% | -12.8% |
| Q2 2021 | $329 | +9.7% | 9,670 | +4.6% | 0.04% | -17.0% |
| Q1 2021 | $300 | -99.9% | 9,242 | -38.8% | 0.05% | -54.4% |
| Q3 2019 | $404,000 | +1.0% | 15,112 | -3.5% | 0.10% | -15.6% |
| Q2 2019 | $400,000 | – | 15,652 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |